P3.01-34 Short Hydration Regimen With a Modified Dose of Magnesium Supplementation for Lung Cancer Patients Receiving Cisplatin-Based Chemotherapy

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1594
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Validity of Short Hydration Regimen of High-Dose Cisplatin-Based Chemotherapy in Patients With Lung Cancer or Malignant Pleural Mesothelioma -Comparison With Usual Hydration-

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
2013English

Renal Protective Effect of a Hydration Supplemented With Magnesium in Patients Receiving Cisplatin for Head and Neck Cancer

Journal of Otolaryngology - Head and Neck Surgery
OtorhinolaryngologySurgery
2018English

Analysis of Nacl-Mannitol Hydration on Renal Function of Head and Neck Cancer Patients Receiving High-Dose Cisplatin Chemotherapy Combination

Folia Medica Indonesiana
2017English

Early Parenteral Supplementation With Glutamine Dipeptide for Acute Myeloid Leukaemia Patients Receiving High Dose Chemotherapy

Journal of High Institute of Public Health
2015English

Hydration Requirements in Patients Receiving Highly Emetogenic Chemotherapy

Future Oncology
MedicineCancer ResearchOncology
2019English

Furosemide Versus Mannitol in Japanese Patients With Thoracic Malignancy Who Received Cisplatin-Based Chemotherapy Using Short Hydration: Study Protocol for a Randomised Controlled Trial

BMJ Open
Medicine
2019English

Feasibility and Efficacy of Adjuvant Chemotherapy With a Split-Dose Regimen of Cisplatin Plus Vinorelbine in Japanese Patients With Completely Resected Stage II-IIIA Non-Small Cell Lung Cancer -A Retrospective Analysis-

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
2013English

Nursing Care for Patients With Non-Small Cell Lung Cancer Receiving Adjuvant Chemotherapy: Evidence–based Implications for Practice

Canadian Oncology Nursing Journal
2008English

Impact of Aprepitant on Emesis Control, Dose Intensity, and Recurrence-Free Survival in a Population-Based Cohort of Head and Neck Cancer Patients Receiving High-Dose Cisplatin Chemotherapy

Journal of Community and Supportive Oncology
OncologyHematology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy